Drug Profile
Amlodipine/candesartan cilexetil - Chong Kun Dang Pharmaceutical
Alternative Names: Candesartan cilexetil/amlodipine - Chong Kun Dang; CKD 330Latest Information Update: 13 Dec 2022
Price :
$50
*
At a glance
- Originator Chong Kun Dang
- Class Antihypertensives; Benzimidazoles; Biphenyl compounds; Dihydropyridines; Heart failure therapies; Ischaemic heart disorder therapies; Small molecules; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Essential hypertension; Hyperlipidaemia; Hypertension
Most Recent Events
- 13 Dec 2022 Discontinued - Phase-I for Hyperlipidaemia (Combination therapy, In volunteers) in South Korea (PO)
- 13 Dec 2022 Discontinued - Phase-I for Hyperlipidaemia (Monotherapy, In volunteers) in South Korea (PO)
- 13 Dec 2022 Discontinued - Phase-I for Hypertension (Combination therapy, In volunteers) in South Korea (PO)